|
1
|
Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
|
Arthritis Rheum
|
2009
|
1.69
|
|
2
|
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody.
|
Rheumatology (Oxford)
|
2009
|
1.62
|
|
3
|
Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
|
Curr Opin Rheumatol
|
2007
|
1.41
|
|
4
|
Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis.
|
Arthritis Rheum
|
2004
|
1.32
|
|
5
|
Neutrophils are essential as a source of IL-17 in the effector phase of arthritis.
|
PLoS One
|
2013
|
1.15
|
|
6
|
Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein.
|
Rheumatology (Oxford)
|
2013
|
1.12
|
|
7
|
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute.
|
J Clin Exp Hematop
|
2013
|
1.05
|
|
8
|
Three groups in the 28 joints for rheumatoid arthritis synovitis--analysis using more than 17,000 assessments in the KURAMA database.
|
PLoS One
|
2013
|
0.98
|
|
9
|
Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4.
|
FEBS Lett
|
2012
|
0.95
|
|
10
|
Recent advances in Takayasu arteritis.
|
Int J Rheum Dis
|
2014
|
0.94
|
|
11
|
Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis.
|
Intern Med
|
2014
|
0.94
|
|
12
|
Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population.
|
Am J Hum Genet
|
2013
|
0.91
|
|
13
|
Successful treatment of a patient with refractory adult Still's disease by tacrolimus.
|
Mod Rheumatol
|
2007
|
0.88
|
|
14
|
[A case of dermatomyositis associated with different types of cancers at intervals of six years].
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2004
|
0.86
|
|
15
|
Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan.
|
Mod Rheumatol
|
2013
|
0.84
|
|
16
|
Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation.
|
J Immunol
|
2011
|
0.83
|
|
17
|
A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
|
J Rheumatol
|
2013
|
0.83
|
|
18
|
Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance.
|
Arthritis Res Ther
|
2012
|
0.81
|
|
19
|
Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.
|
Mod Rheumatol
|
2007
|
0.81
|
|
20
|
Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals.
|
PLoS One
|
2011
|
0.79
|
|
21
|
Sweet's syndrome associated with systemic lupus erythematosus: a case report and review of the literature.
|
J Dermatol
|
2013
|
0.78
|
|
22
|
Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.
|
Arthritis Res Ther
|
2011
|
0.78
|
|
23
|
A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts.
|
Intern Med
|
2016
|
0.75
|
|
24
|
A case of Behçet's disease developing after poststreptococcal acute glomerulonephritis.
|
Mod Rheumatol
|
2012
|
0.75
|
|
25
|
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2016
|
0.75
|
|
26
|
[Susceptibility HLA alleles and amino acids to Takayasu arteritis].
|
Nihon Rinsho Meneki Gakkai Kaishi
|
2014
|
0.75
|
|
27
|
Severe subcutaneous generalized edema in a patient with dermatomyositis.
|
Mod Rheumatol
|
2007
|
0.75
|
|
28
|
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients.
|
Intern Med
|
2016
|
0.75
|
|
29
|
NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA.
|
Mod Rheumatol
|
2012
|
0.75
|